111 Results for "

METH-induced hyperactivity

" in MedChemExpress (MCE) Product Catalog:
Products (111)

111 Results for "METH-induced hyperactivity" in MCE Product Catalog:

Art. -Nr.: HY-B1495
CAS. Nr.: 5786-68-5
Target:  

5-HT Receptor

Forschungsgebiete:  

Neurological Disease

Quipazine maleate is a 5-HT agonist that causes behavioural changes such as hyperactivity. Quipazine maleate also shows a weak reversible MAO inhibitory activity .
loading...
    loading...
Art. -Nr.: HY-139786
CAS. Nr.: 2247669-96-9
Synonyms: ION-827359
Target:  

Sodium Channel

Forschungsgebiete:  

Others

Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
loading...
    loading...
Art. -Nr.: HY-157429
CAS. Nr.: 2865185-31-3
Target:  

5-HT Receptor

Forschungsgebiete:  

Neurological Disease

25N-N1-Nap is a blood-brain barrier-permeable, selective, β-arrestin2-biased 5-HT2A receptor (5-HT2AR) agonist. 25N-N1-Nap reduces Gq efficacy while preserving β-arrestin2 efficacy. 25N-N1-Nap does not induce hallucinogen-like behavioral responses, blocks hyperactivity induced by hallucinogens and psychostimulants, and induces rapid tolerance to hallucinogen-like responses. 25N-N1-Nap can be used for research on schizophrenia-related hyperactivity .
loading...
    loading...
Art. -Nr.: HY-120741
CAS. Nr.: 1798334-07-2
Forschungsgebiete:  

Neurological Disease

PF-04822163 is an orally active, selective, and blood-brain barrier permeable PDE1 inhibitor with IC50 values of 2 nM, 2.4 nM, and 7 nM for PDE1A, PDE1B, and PDE1C respectively. PF-04822163 can be used in the research of attention deficit hyperactivity disorder or Parkinson's disease .
loading...
    loading...
Art. -Nr.: HY-177509
Forschungsgebiete:  

Metabolic Disease

BBL454 (Compound 43) is a Cholecystokinin 2B (CCK2B) receptor agonist. BBL454 induces hyperactivity and improves memory in rat models while it has weak activity on the peripheral CCK2 receptor and no anxiogenic activity. BBL454 increases gastric acid output in anesthetised rat models. BBL454 can be used for diabetes research .
loading...
    loading...
Art. -Nr.: HY-Z0283R
CAS. Nr.: 55-21-0
Synonyms: Benzenecarboxamide (Standard); Phenylamide (Standard)
Benzamide (Standard) is the analytical standard of Benzamide. This product is intended for research and analytical applications. Benzamide (Benzenecarboxamide) is a potent poly(ADP-ribose) polymerase (PARP) inhibitor. Benzamide has protective activity against both glutamate- and methamphetamine (METH)-induced neurotoxicity in vitro. Benzamide can attenuate the METH-induced dopamine depletions and exhibits neuroprotective activity in mice, also has no acute effect on striatal dopamine metabolism and does not reduce body temperature .
loading...
    loading...
Art. -Nr.: HY-17416R
CAS. Nr.: 29110-48-3
Guanfacine (hydrochloride) (Standard) is the analytical standard of Guanfacine (hydrochloride). This product is intended for research and analytical applications. Guanfacine hydrochloride is an orally active noradrenergic α2A agonist and has high selective for the α2A receptor subtype. Guanfacine has effects in producing hypotension and sedation. Guanfacine can be used for the research of a variety of prefrontal cortex (PFC) cognitive disorders, including tourette's syndrome and attention deficit hyperactivity disorder (ADHD) .
loading...
    loading...
Art. -Nr.: HY-17416AS
CAS. Nr.: 1189924-28-4
Guanfacine- 13C, 15N3 is the 13C and 15N labeled Guanfacine . Guanfacine is an orally active noradrenergic α2A agonist and has high selective for the α2A receptor subtype. Guanfacine has effects in producing hypotension and sedation. Guanfacine can be used for the research of a variety of prefrontal cortex (PFC) cognitive disorders, including tourette's syndrome and attention deficit hyperactivity disorder (ADHD) .
loading...
    loading...
Art. -Nr.: HY-107370A
CAS. Nr.: 82857-40-7
Synonyms: (Rac)-Tomoxetine hydrochloride; (Rac)-LY 139603
Forschungsgebiete:  

Metabolic Disease Cancer

(Rac)-Atomoxetine hydrochloride ((Rac)-Tomoxetine (hydrochloride); (Rac)-LY 139603) is the racemic mixture of Atomoxetine hydrochloride (HY-17385). Atomoxetine hydrochloride is a selective noradrenaline reuptake inhibitor with Ki values of 5, 77 and 1451 nM for norepinephrine (NE), serotonin (5-HT) and dopamine (DA) transporters, respectively. Atomoxetine hydrochloride increases of DAEX and NEEX in the PFC and enhances catecholaminergic neurotransmission. Atomoxetine hydrochloride is a potent Na + channels (VGSCs) blocker. Atomoxetine hydrochloride can be used for attention-deficit hyperactivity disorder (ADHD) research .
loading...
    loading...
Art. -Nr.: HY-170499
CAS. Nr.: 3100913-05-8
Synonyms: BI02982816
Target:  

mGluR

Forschungsgebiete:  

Neurological Disease

VU6024578 (BI02982816) is a selective, orally active positive allosteric modulator (PAM) for metabotropic glutamate receptor (mGluR1), that activates human mGluR1 and rat mGluR1 with EC50 of 54 nM and 46 nM. VU6024578 exhibits antipsychotic activity in rats amphetamine-induced hyperactivity models and MK-801 (HY-15084B)-induced novel object recognition (NOR) models. VU6024578 is blood brain barrier penetrable .
loading...
    loading...
Art. -Nr.: HY-106993
CAS. Nr.: 213027-19-1
Reinheit:  99.26%
Synonyms: GT-2331
Target:  

Histamine Receptor

Forschungsgebiete:  

Neurological Disease Endocrinology

Cipralisant (GT-2331) is an orally active, low-toxicity, potent, selective, high affinity histamine H3 receptor full antagonist in vivo, and an agonist in vitro, with a pKi of 9.9 for histamine H3 receptor and a Ki of 0.47 nM for rat histamine H3 receptor. Cipralisant has the potential for attention-deficit hyperactivity disorder research . Cipralisant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Art. -Nr.: HY-15543
CAS. Nr.: 479683-64-2
Target:  

5-HT Receptor

Forschungsgebiete:  

Neurological Disease

CP-809101 is a potent and highly selective 5-HT2C receptor agonist, with pEC50s of 9.96, 7.19 and 6.81 M for human 5HT2C, 5HT2B and 5HT2A receptor. CP-809101 inhibits conditioned avoidance responding in rats and antagonizes both PCP (phencyclidine hydrochloride)- and d-amphetamine-induced hyperactivity. CP-809101 also reduces food and nicotine dependence in rats, can be used in studies of antipsychotic and nicotine dependence .
loading...
    loading...
Art. -Nr.: HY-N9602
CAS. Nr.: 189689-31-4
6,7,4'-Trihydroxyflavanone is a compound with multiple pharmacological activities, including anti-rheumatic, anti-ischemic, anti-inflammatory, anti-osteoclastogenic and protective T-cells from METH-induced deactivation. 6,7,4'-Trihydroxyflavanone has shown potential protective effects in neurotoxicity studies and can be used to inhibit patients with neurodegenerative diseases caused by METH. 6,7,4'-Trihydroxyflavanone inhibits METH-induced neurotoxicity by upregulating the Nrf2/HO-1 and PI3K/Akt/mTOR signaling pathways. 6,7,4'-Trihydroxyflavanone can also induce Nrf2 nuclear translocation and HO-1 expression, further enhancing its protective effect on neuronal cells .
loading...
    loading...
Art. -Nr.: HY-19845
CAS. Nr.: 871351-60-9
Synonyms: ACR-325
Target:  

Dopamine Receptor

Forschungsgebiete:  

Neurological Disease

Ordopidine is a dopamine D2 receptor antagonist. Ordopidine can inhibit hyperactivity caused by psychostimulants. Ordopidine can be used in neurological research .
loading...
    loading...
Art. -Nr.: HY-139786A
Synonyms: ION-827359 sodium
Target:  

Sodium Channel

Forschungsgebiete:  

Others

Cofirasersen sodium is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
loading...
    loading...
Art. -Nr.: HY-109149
CAS. Nr.: 1032291-80-7
Synonyms: KP 106
Target:  

Others

Forschungsgebiete:  

Neurological Disease

Lomardexamfetamine (KP 106) is an orally active central nervous system stimulant composed of d-amphetamine and a ligand. Lomardexamfetamine can be used for the research of attention-deficit hyperactivity disorder .
loading...
    loading...
Art. -Nr.: HY-15413
CAS. Nr.: 1194508-25-2
Synonyms: LY 2216684
Target:  

Adrenergic Receptor

Forschungsgebiete:  

Neurological Disease

Edivoxetine (LY 2216684) is a potent and selective norepinephrine reuptake inhibitor. Edivoxetine can be used for the study of major depressive disorder (MDD) and attention-deficit/hyperactivity disorder (ADHD) .
loading...
    loading...
Art. -Nr.: HY-120076
CAS. Nr.: 179089-90-8
Target:  

Dopamine Receptor

Forschungsgebiete:  

Neurological Disease

CP-293019 is a dopamine D4 receptor antagonist, with a Ki value of 3.4 nM. CP-293019 can inhibit Apomorphine (HY-12723) induced hyperactivity in rats .
loading...
    loading...
Art. -Nr.: HY-14880A
CAS. Nr.: 929622-09-3
Synonyms: JNJ-31001074 dihydrochloride
Target:  

Histamine Receptor

Forschungsgebiete:  

Neurological Disease Endocrinology

Bavisant (JNJ-31001074) dihydrochloride is an orally active, potent, brain-penetrating and highly selective antagonist of the histamine H3 receptor. Bavisant dihydrochloride can be used for attention-deficit hyperactivity disorder (ADHD) research .
loading...
    loading...
Art. -Nr.: HY-19841
CAS. Nr.: 452917-21-4
Target:  

Dopamine Receptor

Forschungsgebiete:  

Neurological Disease

AVE-5997 is a selective b>D3 antagonist. AVE-5997 antagonizes MK-801 (HY-15084B)-induced hyperactivity. AVE-5997 can be used in the research of schizophrenia .
loading...
    loading...